<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="jco"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC4879713/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879713/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Journal of Clinical Oncology"><meta name="citation_title" content="Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy"><meta name="citation_authors" content="Hervé Ghesquieres, Susan L. Slager, Fabrice Jardin, Amelie S. Veron, Yan W. Asmann, Matthew J. Maurer, Thierry Fest, Thomas M. Habermann, Marie C. Bene, Anne J. Novak, Sylvain Mareschal, Corinne Haioun, Thierry Lamy, Stephen M. Ansell, Herve Tilly, Thomas E. Witzig, George J. Weiner, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, Thierry Jo Molina, Brian K. Link, Noel Milpied, David G. Cox, Gilles A. Salles, James R. Cerhan"><meta name="citation_date" content="20 November 2015"><meta name="citation_issue" content="33"><meta name="citation_volume" content="33"><meta name="citation_firstpage" content="3930"><meta name="citation_doi" content="10.1200/JCO.2014.60.2573"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4879713/?report=abstract"><meta name="citation_pmid" content="26460308"><meta name="DC.Title" content="Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="American Society of Clinical Oncology"><meta name="DC.Contributor" content="Hervé Ghesquieres"><meta name="DC.Contributor" content="Susan L. Slager"><meta name="DC.Contributor" content="Fabrice Jardin"><meta name="DC.Contributor" content="Amelie S. Veron"><meta name="DC.Contributor" content="Yan W. Asmann"><meta name="DC.Contributor" content="Matthew J. Maurer"><meta name="DC.Contributor" content="Thierry Fest"><meta name="DC.Contributor" content="Thomas M. Habermann"><meta name="DC.Contributor" content="Marie C. Bene"><meta name="DC.Contributor" content="Anne J. Novak"><meta name="DC.Contributor" content="Sylvain Mareschal"><meta name="DC.Contributor" content="Corinne Haioun"><meta name="DC.Contributor" content="Thierry Lamy"><meta name="DC.Contributor" content="Stephen M. Ansell"><meta name="DC.Contributor" content="Herve Tilly"><meta name="DC.Contributor" content="Thomas E. Witzig"><meta name="DC.Contributor" content="George J. Weiner"><meta name="DC.Contributor" content="Andrew L. Feldman"><meta name="DC.Contributor" content="Ahmet Dogan"><meta name="DC.Contributor" content="Julie M. Cunningham"><meta name="DC.Contributor" content="Curtis L. Olswold"><meta name="DC.Contributor" content="Thierry Jo Molina"><meta name="DC.Contributor" content="Brian K. Link"><meta name="DC.Contributor" content="Noel Milpied"><meta name="DC.Contributor" content="David G. Cox"><meta name="DC.Contributor" content="Gilles A. Salles"><meta name="DC.Contributor" content="James R. Cerhan"><meta name="DC.Date" content="2015 Nov 20"><meta name="DC.Identifier" content="10.1200/JCO.2014.60.2573"><meta name="DC.Language" content="en"><meta property="og:title" content="Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy"><meta property="og:type" content="article"><meta property="og:description" content="We performed a multistage genome-wide association study to identify inherited genetic variants that predict outcome in diffuse large B-cell lymphoma patients treated with immunochemotherapy.We conducted a meta-analysis of two genome-wide association study ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879713/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-jco.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC4879713/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC4879713/pdf/zlj3930.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8A2777DD5868D10000000005F2035A.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4879713%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=%22J Clin Oncol%22[journal]" class="navlink">J Clin Oncol</a></li><li class="accid">PMC4879713</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-jco.gif" alt="Logo of jco" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,56,105,76" alt="Home" title="Home" href="http://jco.ascopubs.org" ref="reftype=publisher&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="104,56,258,76" alt="This Article" title="This Article" href="http://jco.ascopubs.org/cgi/content/full/33/33/3930" ref="reftype=publisher&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7CArticle%7CFullText" target="pmc_ext"><area shape="rect" coords="0,0,157,57" href="http://jco.ascopubs.org/" ref="reftype=publisher&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="257,56,380,76" alt="Search" title="Search" href="http://jco.ascopubs.org/search.dtl" ref="reftype=publisher&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="379,56,500,77" alt="Submit" title="Submit" href="http://submit.jco.org/" ref="reftype=publisher&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="poly" coords="450,2,431,9,425,27,429,43,437,54,459,55,471,52,483,42,486,29,479,11,466,2,449,2" alt="ASCO JCO Homepage" title="ASCO JCO Homepage" href="http://jco.ascopubs.org" ref="reftype=publisher&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">J Clin Oncol</a></span>. 2015 Nov 20; 33(33): 3930–3937. </span></div><div><span class="fm-vol-iss-date">Published online 2015 Oct 12. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1200%2FJCO.2014.60.2573" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1200/JCO.2014.60.2573</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4879713</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/26460308">26460308</a></div></div></div></div><h1 class="content-title">Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Ghesquieres%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044664270304" co-class="co-affbox">Hervé Ghesquieres</a>,<sup></sup> <a href="/pubmed/?term=Slager%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044671563168" co-class="co-affbox">Susan L. Slager</a>,<sup></sup> <a href="/pubmed/?term=Jardin%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044664268320" co-class="co-affbox">Fabrice Jardin</a>,<sup></sup> <a href="/pubmed/?term=Veron%20AS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044664266576" co-class="co-affbox">Amelie S. Veron</a>,<sup></sup> <a href="/pubmed/?term=Asmann%20YW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044674332240" co-class="co-affbox">Yan W. Asmann</a>,<sup></sup> <a href="/pubmed/?term=Maurer%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044674330384" co-class="co-affbox">Matthew J. Maurer</a>,<sup></sup> <a href="/pubmed/?term=Fest%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044674328528" co-class="co-affbox">Thierry Fest</a>,<sup></sup> <a href="/pubmed/?term=Habermann%20TM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044674326672" co-class="co-affbox">Thomas M. Habermann</a>,<sup></sup> <a href="/pubmed/?term=Bene%20MC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044669636384" co-class="co-affbox">Marie C. Bene</a>,<sup></sup> <a href="/pubmed/?term=Novak%20AJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044669634528" co-class="co-affbox">Anne J. Novak</a>,<sup></sup> <a href="/pubmed/?term=Mareschal%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044669632672" co-class="co-affbox">Sylvain Mareschal</a>,<sup></sup> <a href="/pubmed/?term=Haioun%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044669630816" co-class="co-affbox">Corinne Haioun</a>,<sup></sup> <a href="/pubmed/?term=Lamy%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044669993600" co-class="co-affbox">Thierry Lamy</a>,<sup></sup> <a href="/pubmed/?term=Ansell%20SM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044669991744" co-class="co-affbox">Stephen M. Ansell</a>,<sup></sup> <a href="/pubmed/?term=Tilly%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044669989888" co-class="co-affbox">Herve Tilly</a>,<sup></sup> <a href="/pubmed/?term=Witzig%20TE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044669988032" co-class="co-affbox">Thomas E. Witzig</a>,<sup></sup> <a href="/pubmed/?term=Weiner%20GJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044673312800" co-class="co-affbox">George J. Weiner</a>,<sup></sup> <a href="/pubmed/?term=Feldman%20AL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044673310944" co-class="co-affbox">Andrew L. Feldman</a>,<sup></sup> <a href="/pubmed/?term=Dogan%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044673309088" co-class="co-affbox">Ahmet Dogan</a>,<sup></sup> <a href="/pubmed/?term=Cunningham%20JM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044673307232" co-class="co-affbox">Julie M. Cunningham</a>,<sup></sup> <a href="/pubmed/?term=Olswold%20CL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044705801424" co-class="co-affbox">Curtis L. Olswold</a>,<sup></sup> <a href="/pubmed/?term=Molina%20TJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044705799568" co-class="co-affbox">Thierry Jo Molina</a>,<sup></sup> <a href="/pubmed/?term=Link%20BK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044705797712" co-class="co-affbox">Brian K. Link</a>,<sup></sup> <a href="/pubmed/?term=Milpied%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044705795856" co-class="co-affbox">Noel Milpied</a>,<sup></sup> <a href="/pubmed/?term=Cox%20DG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044705794000" co-class="co-affbox">David G. Cox</a>,<sup></sup> <a href="/pubmed/?term=Salles%20GA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044668012192" co-class="co-affbox">Gilles A. Salles</a>,<sup></sup> and  <a href="/pubmed/?term=Cerhan%20JR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308" class="affpopup" co-rid="_co_idm140044668010336" co-class="co-affbox">James R. Cerhan</a><sup></sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140044664270304"><h3 class="no_margin">Hervé Ghesquieres</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Ghesquieres%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Hervé Ghesquieres</a></div></div><div id="_co_idm140044671563168"><h3 class="no_margin">Susan L. Slager</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Slager%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Susan L. Slager</a></div></div><div id="_co_idm140044664268320"><h3 class="no_margin">Fabrice Jardin</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Jardin%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Fabrice Jardin</a></div></div><div id="_co_idm140044664266576"><h3 class="no_margin">Amelie S. Veron</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Veron%20AS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Amelie S. Veron</a></div></div><div id="_co_idm140044674332240"><h3 class="no_margin">Yan W. Asmann</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Asmann%20YW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Yan W. Asmann</a></div></div><div id="_co_idm140044674330384"><h3 class="no_margin">Matthew J. Maurer</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Maurer%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Matthew J. Maurer</a></div></div><div id="_co_idm140044674328528"><h3 class="no_margin">Thierry Fest</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Fest%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Thierry Fest</a></div></div><div id="_co_idm140044674326672"><h3 class="no_margin">Thomas M. Habermann</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Habermann%20TM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Thomas M. Habermann</a></div></div><div id="_co_idm140044669636384"><h3 class="no_margin">Marie C. Bene</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Bene%20MC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Marie C. Bene</a></div></div><div id="_co_idm140044669634528"><h3 class="no_margin">Anne J. Novak</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Novak%20AJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Anne J. Novak</a></div></div><div id="_co_idm140044669632672"><h3 class="no_margin">Sylvain Mareschal</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Mareschal%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Sylvain Mareschal</a></div></div><div id="_co_idm140044669630816"><h3 class="no_margin">Corinne Haioun</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Haioun%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Corinne Haioun</a></div></div><div id="_co_idm140044669993600"><h3 class="no_margin">Thierry Lamy</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Lamy%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Thierry Lamy</a></div></div><div id="_co_idm140044669991744"><h3 class="no_margin">Stephen M. Ansell</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Ansell%20SM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Stephen M. Ansell</a></div></div><div id="_co_idm140044669989888"><h3 class="no_margin">Herve Tilly</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Tilly%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Herve Tilly</a></div></div><div id="_co_idm140044669988032"><h3 class="no_margin">Thomas E. Witzig</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Witzig%20TE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Thomas E. Witzig</a></div></div><div id="_co_idm140044673312800"><h3 class="no_margin">George J. Weiner</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Weiner%20GJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">George J. Weiner</a></div></div><div id="_co_idm140044673310944"><h3 class="no_margin">Andrew L. Feldman</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Feldman%20AL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Andrew L. Feldman</a></div></div><div id="_co_idm140044673309088"><h3 class="no_margin">Ahmet Dogan</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Dogan%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Ahmet Dogan</a></div></div><div id="_co_idm140044673307232"><h3 class="no_margin">Julie M. Cunningham</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Cunningham%20JM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Julie M. Cunningham</a></div></div><div id="_co_idm140044705801424"><h3 class="no_margin">Curtis L. Olswold</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Olswold%20CL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Curtis L. Olswold</a></div></div><div id="_co_idm140044705799568"><h3 class="no_margin">Thierry Jo Molina</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Molina%20TJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Thierry Jo Molina</a></div></div><div id="_co_idm140044705797712"><h3 class="no_margin">Brian K. Link</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Link%20BK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Brian K. Link</a></div></div><div id="_co_idm140044705795856"><h3 class="no_margin">Noel Milpied</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Milpied%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Noel Milpied</a></div></div><div id="_co_idm140044705794000"><h3 class="no_margin">David G. Cox</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Cox%20DG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">David G. Cox</a></div></div><div id="_co_idm140044668012192"><h3 class="no_margin">Gilles A. Salles</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Salles%20GA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">Gilles A. Salles</a></div></div><div id="_co_idm140044668010336"><h3 class="no_margin">James R. Cerhan</h3><p>Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</p><div>Find articles by <a href="/pubmed/?term=Cerhan%20JR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26460308">James R. Cerhan</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140044670823584_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140044670823584_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140044670823584_ai" style="display:none"><div class="fm-affl" id="aff1" lang="en">Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique–Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.</div><div id="idm140044670468800">G.A.S. and J.R.C. contributed equally to this article.</div><div id="cor1">Corresponding author: James R. Cerhan, MD, PhD, Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN 55905; e-mail: <a href="mailto:dev@null" data-email="ude.oyam@semaj.nahrec" class="oemail">ude.oyam@semaj.nahrec</a>.</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140044670823584_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> © 2015 by American Society of Clinical Oncology</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC4879713/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">
Data Supplement
</div>

<div><a href="/pmc/articles/PMC4879713/bin/supp_33_33_3930__index.html" data-ga-action="click_feat_suppl">supp_33_33_3930__index.html</a><span style="color:gray"> (2.1K)</span></div><div class="small guid">GUID:&nbsp;1917F29A-BF6A-465F-9F6F-172D5EFE0424</div>
<div><a href="/pmc/articles/PMC4879713/bin/supp_JCO.2014.60.2573_DS_2014.602573.pdf" data-ga-action="click_feat_suppl">supp_JCO.2014.60.2573_DS_2014.602573.pdf</a><span style="color:gray"> (448K)</span></div><div class="small guid">GUID:&nbsp;8C3F991A-B72A-4BDC-9018-C47F7DB0BDF4</div>
</div></dd></dl></div><div id="idm140044666014224" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140044666014224title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Purpose</h3><p id="__p2" class="p p-first-last">We performed a multistage genome-wide association study to identify inherited genetic variants that predict outcome in diffuse large B-cell lymphoma patients treated with immunochemotherapy.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p3" class="p p-first-last">We conducted a meta-analysis of two genome-wide association study data sets, one from the LNH2003B trial (N = 540), a prospective clinical trial from the Lymphoma Study Association, and the other from the Molecular Epidemiology Resource study (N = 312), a prospective observational study from the University of Iowa–Mayo Clinic Lymphoma Specialized Program of Research Excellence. Top single nucleotide polymorphisms were then genotyped in independent cohorts of patients from the Specialized Program of Research Excellence (N = 391) and the Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang (GOELAMS) -075 randomized trial (N = 294). We calculated the hazard ratios (HRs) and 95% CIs for event-free survival (EFS) and overall survival (OS) using a log-additive genetic model with adjustment for age, sex, and age-adjusted International Prognostic Index.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p4" class="p p-first-last">In a meta-analysis of the four studies, the top loci for EFS were marked by rs7712513 at 5q23.2 (near <em>SNX2</em> and <em>SNCAIP</em>; HR, 1.39; 95% CI, 1.23 to 1.57; <em>P</em> = 2.08 × 10<sup>−7</sup>), and rs7765004 at 6q21 (near <em>MARCKS</em> and <em>HDAC2</em>; HR, 1.38; 95% CI, 1.22 to 1.57; <em>P</em> = 7.09 × 10<sup>−7</sup>), although they did not reach conventional genome-wide significance (<em>P</em> = 5 × 10<sup>−8</sup>). Both rs7712513 (HR, 1.49; 95% CI, 1.29 to 1.72; <em>P</em> = 3.53 × 10<sup>−8</sup>) and rs7765004 (HR, 1.47; 95% CI, 1.27 to 1.71; <em>P</em> = 5.36 × 10<sup>−7</sup>) were also associated with OS. In exploratory analyses, a two–single nucleotide polymorphism risk score was highly predictive of EFS (<em>P</em> = 1.78 × 10<sup>−12</sup>) and was independent of treatment, IPI, and cell-of-origin classification.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusion</h3><p id="__p5" class="p p-first-last">Our study provides encouraging evidence for associations between loci at 5q23.2 and 6q21 with EFS and OS in patients with diffuse large B-cell lymphoma treated with immunochemotherapy, suggesting novel biology and the potential contribution of host genetics to the prognosis of this aggressive malignancy.</p></div></div></div><div id="__sec5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec5title">INTRODUCTION</h2><p id="__p6" class="p p-first">Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma subtype, and approximately 60% of patients with DLBCL are cured with rituximab, doxorubicin, cyclophosphamide, vincristine, and prednisone (R-CHOP) treatment.<sup><a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996574">1</a></sup> However, the clinical course is heterogeneous, and new biomarkers are needed to better delineate patient outcome, adapt treatment strategy, and identify novel treatment targets. The most commonly used tool for prognostication of patients with DLBCL is the International Prognostic Index (IPI), which is based on conventional clinical and pathology parameters.<sup><a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996558">2</a></sup> Although it has clinical utility, the IPI does not reflect the biologic heterogeneity of DLBCL. Gene expression profiling of DLBCL tumors from patients treated with R-CHOP has led to advances in the understanding of the pathogenesis, delineating the importance of cell of origin (germinal center <em>v</em> activated B-cell signature) and the potential role for non-neoplastic cells in the tumor microenvironment.<sup><a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996559">3</a></sup></p><p id="__p7" class="p p-last">The role of host genetic background (macroenvironment) in relation to patient outcome is less studied. Although there are promising leads for genetic variation in candidate genes and pathways related to metabolism, immune function, and DNA repair impacting outcomes,<sup><a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996561">4</a>–<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996585">10</a></sup> most studies to date have been limited by small sample sizes, have lacked robust replication, have had minimal clinical details, or were conducted in cohorts with unknown, old (prerituximab era), or highly heterogeneous treatments. Compared with the candidate gene approach, the agnostic genome-wide approach has been much more successful in identifying genetic variants linked to cancer risk, but to our knowledge, no comprehensive genome-wide association study (GWAS) has been conducted to identify genetic markers for DLBCL prognosis. In this context, we conducted a multistage GWAS to identify novel loci associated with DLBCL prognosis in patients treated with immunochemotherapy.</p></div><div id="__sec6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec6title">METHODS</h2><div id="__sec7" class="sec sec-first"><h3 id="__sec7title">Study Design and Populations</h3><p id="__p8" class="p p-first">We performed a multistage analysis to discover genetic loci associated with DLBCL event-free survival (EFS; Data Supplement); a priori power calculations were not conducted. In the first stage, we conducted a meta-analysis of GWAS data from the Lymphoma Study Association (LYSA) prospective LNH03B clinical trial program (France) and the Molecular Epidemiology Resource from the University of Iowa/Mayo Clinic (United States) Lymphoma Specialized Program of Research Excellence (SPORE). The French cohort consisted of a subset of patients with DLBCL (N = 540) with GWAS data from the LNH03B program.<sup><a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996563">11</a>–<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996575">15</a></sup> The US cohort consisted of 312 patients with newly diagnosed DLBCL and treated with immunochemotherapy who were prospectively enrolled onto an observational cohort as part of the SPORE (SPORE-I).<sup><a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996569">16</a></sup> In the second stage, significant single nucleotide polymorphisms (SNPs) from the meta-analysis were evaluated in 391 additional patients with DLBCL from the SPORE (SPORE-II) and 294 patients with DLBCL included in the prospective Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang (GOELAMS) -075 trial.<sup><a href="#B17" rid="B17" class=" bibr popnode">17</a></sup> For all studies, diagnoses were reviewed and confirmed by study hematopathologists, and cell of origin was defined as germinal center B-cell (GCB) versus non-GCB DLBCL using a published algorithm.<sup><a href="#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996562">18</a></sup> Further details are provided in the Data Supplement.</p><p id="__p9" class="p p-last">This study was conducted in accordance with the Declaration of Helsinki. The LYSA-03B and GOELAMS-075 studies were approved by the Ethics Committee Haute-Normandie and Nantes University Hospital, respectively. The SPORE studies were approved by the Human Subjects Review Boards at Mayo Clinic and the University of Iowa. All patients provided written consent for participation, including genetic analyses.</p></div><div id="__sec8" class="sec"><h3 id="__sec8title">Genotyping and Imputation</h3><p id="__p10" class="p p-first-last">The LYSA-03B samples were genotyped at Centre National de Genetique (Evry, France) using the Illumina HapMap 610K BeadChip (Illumina, San Diego, CA). The SPORE-I samples were genotyped at the Genotyping Shared Resource at the Mayo Clinic (Rochester, MN) using the Illumina 660Quad BeadChip. Standard quality control measures for genotyping were implemented (Data Supplement). Patients with less than 80% European ancestry were excluded after principal components analysis. To standardize genotyping across the GWAS and facilitate meta-analysis, we imputed participant-level genotyping data using MACH 1.0 software (<a href="http://csg.sph.umich.edu//abecasis/MACH/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://csg.sph.umich.edu//abecasis/MACH/</a>) with HapMap2 as a reference. We used the Illumina VeraCode custom platform to genotype the top SNPs for technical validation in SPORE-I and for stage 2 analyses in the SPORE-II and the GOELAMS-075 trial (Data Supplement).</p></div><div id="__sec9" class="sec sec-last"><h3 id="__sec9title">Statistical Analyses</h3><p id="__p11" class="p p-first">EFS was the primary end point and was defined as the time from date of random assignment (LYSA-03B and GOELAMS-075) or diagnosis (SPORE cohorts) to the date of disease progression, relapse, re-treatment, or death from any cause. For those SNPs of interest from the EFS analyses, we evaluated overall survival (OS) as a secondary end point. Hazard ratios (HRs) and 95% CIs for the association of SNPs with EFS and OS were estimated using Cox regression analysis and a log-additive (per allele) genetic model. All models were adjusted for age, sex, and age-adjusted IPI (aaIPI).</p><p id="__p12">For the first stage, the LYSA-03B and SPORE-I studies were combined using the fixed-effects inverse variance method based on the β estimates and SEs from each study. From the top SNPs for EFS (genotyped or imputed), we selected 76 SNPs for evaluation along with 12 additional potentially functional SNPs based on a bioinformatics analysis of top regions (Data Supplement). Of the 76 SNPs genotyped in the second stage from the SPORE-II and GOELAMS-075 cohorts, two failed genotyping and one was monomorphic, leaving 73 SNPs for analysis. All 12 potentially functional SNPs were successfully genotyped. The final decision of statistical significance was based on the pooled analysis<sup><a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996580">19</a></sup> of all four cohorts and the current GWAS statistical significance threshold of <em>P</em> &lt; 5 × 10<sup>−8</sup>. Meta-analyses were performed on Cox model summary statistics<sup><a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996576">20</a></sup> analogous to the approach used in the software package METAL (<a href="http://csg.sph.umich.edu//abecasis/Metal/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://csg.sph.umich.edu//abecasis/Metal/</a>).<sup><a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996587">21</a></sup></p><p id="__p13" class="p p-last">In secondary analyses of the replicated SNPs, we pooled the four data sets. We first assessed the SNP associations by cell of origin. Next, we created an SNP score by summing the number of deleterious alleles from the top SNPs that showed robust replication. Kaplan-Meier plots were generated to depict time to EFS by multi-SNP score categories. The multi-SNP score was then fit using a Cox model to adjust for potential confounding factors. We used c-statistics to compare the prognostic ability of the survival models.<sup><a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996565">22</a></sup> Wald tests using a multiplicative interaction term between the multi-SNP score and aaIPI or cell of origin were conducted. We correlated newly identified loci with gene expression and used multiple bioinformatics tools to assess potential functional impacts with public data sets (Data Supplement).</p></div></div><div id="__sec10" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec10title">RESULTS</h2><div id="__sec11" class="sec sec-first"><h3 id="__sec11title">Study Patients</h3><p id="__p14" class="p p-first">The four study cohorts had broadly similar clinical characteristics (<a href="/pmc/articles/PMC4879713/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>), although the GOELAMS-075 cohort had a younger median age of 49 years (range, 18 to 60 years) as a result of the trial upper age eligibility. The majority of patients were treated with R-CHOP; in LYSA-03B, 37% of the patients were treated with rituximab, doxorubicin, vindesine, bleomycin, and prednisone, and in GOELAMS-075, 48% of the patients were treated with rituximab, cyclophosphamide, epirubicin, vindesine, and prednisone followed by transplantation (Data Supplement). The 2-year EFS rates were 72%, 71%, and 70% for SPORE-I, LYSA-03B, and SPORE-II, respectively, whereas in GOELAMS-075, the 2-year EFS rate was 80%.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1.</h3><!--caption a7--><div class="caption"><p id="__p15">Clinical Characteristics and Outcome of Patients in the First- and Second-Stage Cohorts</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140044671656768" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th rowspan="3" colspan="1" align="center">Characteristic</th><th colspan="5" rowspan="1" align="center">No. of Patients (%)<hr></th></tr><tr><th colspan="2" rowspan="1" align="center">First-Stage Cohorts<hr></th><th colspan="2" rowspan="1" align="center">Second-Stage Cohorts<hr></th><th rowspan="2" colspan="1" align="center">Pooled (N = 1,537)</th></tr><tr><th rowspan="1" colspan="1" align="center">LYSA-03B (n = 540)</th><th rowspan="1" colspan="1" align="center">SPORE-I (n = 312)</th><th rowspan="1" colspan="1" align="center">SPORE-II (n = 391)</th><th rowspan="1" colspan="1" align="center">GOELAMS-075 (n = 294)</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left">Age, years</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    Median</td><td rowspan="1" colspan="1" align="center">61</td><td rowspan="1" colspan="1" align="center">63</td><td rowspan="1" colspan="1" align="center">61</td><td rowspan="1" colspan="1" align="center">49</td><td rowspan="1" colspan="1" align="center">58</td></tr><tr><td rowspan="1" colspan="1" align="left">    Range</td><td rowspan="1" colspan="1" align="center">18-93</td><td rowspan="1" colspan="1" align="center">20-92</td><td rowspan="1" colspan="1" align="center">18-88</td><td rowspan="1" colspan="1" align="center">18-60</td><td rowspan="1" colspan="1" align="center">18-93</td></tr><tr><td rowspan="1" colspan="1" align="left">    &gt; 60</td><td rowspan="1" colspan="1" align="center">270 (50)</td><td rowspan="1" colspan="1" align="center">185 (59)</td><td rowspan="1" colspan="1" align="center">200 (51)</td><td rowspan="1" colspan="1" align="center">0 (0)</td><td rowspan="1" colspan="1" align="center">655 (43)</td></tr><tr><td rowspan="1" colspan="1" align="left">Male</td><td rowspan="1" colspan="1" align="center">307 (57)</td><td rowspan="1" colspan="1" align="center">156 (50)</td><td rowspan="1" colspan="1" align="center">229 (59)</td><td rowspan="1" colspan="1" align="center">174 (59)</td><td rowspan="1" colspan="1" align="center">865 (56)</td></tr><tr><td rowspan="1" colspan="1" align="left">ECOG PS ≥ 2</td><td rowspan="1" colspan="1" align="center">101 (19)</td><td rowspan="1" colspan="1" align="center">34 (11)</td><td rowspan="1" colspan="1" align="center">79 (20)</td><td rowspan="1" colspan="1" align="center">45 (15)</td><td rowspan="1" colspan="1" align="center">259 (17)</td></tr><tr><td rowspan="1" colspan="1" align="left">LDH &gt; ULN</td><td rowspan="1" colspan="1" align="center">217 (40)</td><td rowspan="1" colspan="1" align="center">164 (53)</td><td rowspan="1" colspan="1" align="center">189 (548)</td><td rowspan="1" colspan="1" align="center">213 (72)</td><td rowspan="1" colspan="1" align="center">783 (51)</td></tr><tr><td rowspan="1" colspan="1" align="left">Stage III/IV</td><td rowspan="1" colspan="1" align="center">394 (73)</td><td rowspan="1" colspan="1" align="center">182 (58)</td><td rowspan="1" colspan="1" align="center">244 (62)</td><td rowspan="1" colspan="1" align="center">196 (67)</td><td rowspan="1" colspan="1" align="center">830 (66)</td></tr><tr><td rowspan="1" colspan="1" align="left">≥ 2 extranodal sites</td><td rowspan="1" colspan="1" align="center">212 (39)</td><td rowspan="1" colspan="1" align="center">72 (23)</td><td rowspan="1" colspan="1" align="center">71 (18)</td><td rowspan="1" colspan="1" align="center">120 (41)</td><td rowspan="1" colspan="1" align="center">475 (31)</td></tr><tr><td rowspan="1" colspan="1" align="left">“B” symptoms</td><td rowspan="1" colspan="1" align="center">193 (36)</td><td rowspan="1" colspan="1" align="center">70 (22)</td><td rowspan="1" colspan="1" align="center">96 (25)</td><td rowspan="1" colspan="1" align="center">126 (43)</td><td rowspan="1" colspan="1" align="center">485 (32)</td></tr><tr><td rowspan="1" colspan="1" align="left">BM involvement</td><td rowspan="1" colspan="1" align="center">74 (14)</td><td rowspan="1" colspan="1" align="center">49 (16)</td><td rowspan="1" colspan="1" align="center">69 (18)</td><td rowspan="1" colspan="1" align="center">45 (15)</td><td rowspan="1" colspan="1" align="center">237 (15)</td></tr><tr><td rowspan="1" colspan="1" align="left">Bulky disease</td><td rowspan="1" colspan="1" align="center">114 (21)</td><td rowspan="1" colspan="1" align="center">38 (12)</td><td rowspan="1" colspan="1" align="center">50 (13)</td><td rowspan="1" colspan="1" align="center">180 (61)</td><td rowspan="1" colspan="1" align="center">382 (25)</td></tr><tr><td rowspan="1" colspan="1" align="left">aaIPI</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    0-1</td><td rowspan="1" colspan="1" align="center">271 (50)</td><td rowspan="1" colspan="1" align="center">186 (60)</td><td rowspan="1" colspan="1" align="center">223 (56)</td><td rowspan="1" colspan="1" align="center">121 (41)</td><td rowspan="1" colspan="1" align="center">801 (52)</td></tr><tr><td rowspan="1" colspan="1" align="left">    2</td><td rowspan="1" colspan="1" align="center">199 (37)</td><td rowspan="1" colspan="1" align="center">99 (32)</td><td rowspan="1" colspan="1" align="center">123 (31)</td><td rowspan="1" colspan="1" align="center">141 (48)</td><td rowspan="1" colspan="1" align="center">562 (37)</td></tr><tr><td rowspan="1" colspan="1" align="left">    3</td><td rowspan="1" colspan="1" align="center">70 (13)</td><td rowspan="1" colspan="1" align="center">27 (9)</td><td rowspan="1" colspan="1" align="center">45 (12)</td><td rowspan="1" colspan="1" align="center">32 (11)</td><td rowspan="1" colspan="1" align="center">174 (11)</td></tr><tr><td rowspan="1" colspan="1" align="left">Cell of origin</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    GCB</td><td rowspan="1" colspan="1" align="center">132 (46)</td><td rowspan="1" colspan="1" align="center">106 (62)</td><td rowspan="1" colspan="1" align="center">128 (65)</td><td rowspan="1" colspan="1" align="center">49 (50)</td><td rowspan="1" colspan="1" align="center">415 (55)</td></tr><tr><td rowspan="1" colspan="1" align="left">    Non-GCB</td><td rowspan="1" colspan="1" align="center">152 (54)</td><td rowspan="1" colspan="1" align="center">66 (38)</td><td rowspan="1" colspan="1" align="center">69 (35)</td><td rowspan="1" colspan="1" align="center">49 (50)</td><td rowspan="1" colspan="1" align="center">336 (45)</td></tr><tr><td rowspan="1" colspan="1" align="left">    Unknown</td><td rowspan="1" colspan="1" align="center">256</td><td rowspan="1" colspan="1" align="center">140</td><td rowspan="1" colspan="1" align="center">194</td><td rowspan="1" colspan="1" align="center">196</td><td rowspan="1" colspan="1" align="center">786</td></tr><tr><td rowspan="1" colspan="1" align="left">Treatment</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    R-CHOP</td><td rowspan="1" colspan="1" align="center">341 (63)</td><td rowspan="1" colspan="1" align="center">274 (88)</td><td rowspan="1" colspan="1" align="center">327 (84)</td><td rowspan="1" colspan="1" align="center">154 (52)</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    Others</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">38 (12)</td><td rowspan="1" colspan="1" align="center">64 (16)</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    R-ACVBP</td><td rowspan="1" colspan="1" align="center">199 (37)</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    R-CEEP</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">0</td><td rowspan="1" colspan="1" align="center">140 (48)</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">Overall follow-up, months</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    Median</td><td rowspan="1" colspan="1" align="center">32</td><td rowspan="1" colspan="1" align="center">60</td><td rowspan="1" colspan="1" align="center">37</td><td rowspan="1" colspan="1" align="center">46</td><td rowspan="1" colspan="1" align="center">41</td></tr><tr><td rowspan="1" colspan="1" align="left">    Range</td><td rowspan="1" colspan="1" align="center">1-85</td><td rowspan="1" colspan="1" align="center">1-127</td><td rowspan="1" colspan="1" align="center">1-129</td><td rowspan="1" colspan="1" align="center">1-92</td><td rowspan="1" colspan="1" align="center">1-129</td></tr><tr><td rowspan="1" colspan="1" align="left">Follow-up of alive patients, months</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    Median</td><td rowspan="1" colspan="1" align="center">39</td><td rowspan="1" colspan="1" align="center">72</td><td rowspan="1" colspan="1" align="center">47</td><td rowspan="1" colspan="1" align="center">51</td><td rowspan="1" colspan="1" align="center">48</td></tr><tr><td rowspan="1" colspan="1" align="left">    Range</td><td rowspan="1" colspan="1" align="center">1-85</td><td rowspan="1" colspan="1" align="center">8-126</td><td rowspan="1" colspan="1" align="center">6-129</td><td rowspan="1" colspan="1" align="center">5-92</td><td rowspan="1" colspan="1" align="center">1-129</td></tr><tr><td rowspan="1" colspan="1" align="left">Events</td><td rowspan="1" colspan="1" align="center">176 (33)</td><td rowspan="1" colspan="1" align="center">133 (43)</td><td rowspan="1" colspan="1" align="center">145 (37)</td><td rowspan="1" colspan="1" align="center">75 (26)</td><td rowspan="1" colspan="1" align="center">529 (34)</td></tr><tr><td rowspan="1" colspan="1" align="left">Deaths</td><td rowspan="1" colspan="1" align="center">134 (25)</td><td rowspan="1" colspan="1" align="center">104 (33)</td><td rowspan="1" colspan="1" align="center">96 (25)</td><td rowspan="1" colspan="1" align="center">50 (17)</td><td rowspan="1" colspan="1" align="center">384 (25)</td></tr><tr><td rowspan="1" colspan="1" align="left">2-Year EFS</td><td rowspan="1" colspan="1" align="center">71</td><td rowspan="1" colspan="1" align="center">72</td><td rowspan="1" colspan="1" align="center">70</td><td rowspan="1" colspan="1" align="center">80</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    95% CI</td><td rowspan="1" colspan="1" align="center">66-76</td><td rowspan="1" colspan="1" align="center">67-77</td><td rowspan="1" colspan="1" align="center">66-75</td><td rowspan="1" colspan="1" align="center">75-84</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">2-Year OS</td><td rowspan="1" colspan="1" align="center">83</td><td rowspan="1" colspan="1" align="center">81</td><td rowspan="1" colspan="1" align="center">82</td><td rowspan="1" colspan="1" align="center">88</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    95% CI</td><td rowspan="1" colspan="1" align="center">79-87</td><td rowspan="1" colspan="1" align="center">77-85</td><td rowspan="1" colspan="1" align="center">79-86</td><td rowspan="1" colspan="1" align="center">84-91</td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140044671656768" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4879713/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140044673318864"><p id="__p16" class="p p-first-last">Abbreviations: aaIPI, age-adjusted International Prognostic Index; BM, bone marrow; ECOG PS, Eastern Cooperative Oncology Group performance status; EFS, event-free survival; GCB, germinal center B cell; GOELAMS, Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang; LDH, lactate dehydrogenase; LYSA, Lymphoma Study Association; OS, overall survival; R-ACVBP, rituximab, doxorubicin, vindesine, bleomycin, and prednisone; R-CEEP, rituximab, cyclophosphamide, epirubicin, vindesine, and prednisone; R-CHOP, rituximab, doxorubicin, cyclophosphamide, vincristine, and prednisone; SPORE, Specialized Program of Research Excellence; ULN, upper limit of normal.</p></div></div></div></div><div id="__sec12" class="sec"><h3 id="__sec12title">SNPs Associated With EFS</h3><p id="__p17" class="p p-first">In the first stage, the distribution of <em>P</em> values (observed and imputed) for the association of SNPs with EFS matched the expected distribution with a modest excess of significant associations for the LYSA-03B and SPORE-I studies (see quantile-quantile plots in Data Supplement). In the initial meta-analysis of these two studies only, one SNP (rs9298183) achieved genome-wide significance (<em>P</em> &lt; 5 × 10<sup>−8</sup>).</p><p id="__p18">The 73 top SNPs selected for second-stage analyses, along with 12 additional SNPs from the same regions selected for potential functional relevance, were genotyped in the SPORE-I samples (for technical validation) and in independent samples in SPORE-II and GOELAMS-075 (Data Supplement). The results for EFS, adjusted for age, sex, and aaIPI, in the second-stage cohorts and a meta-analysis of all four studies are provided in the Data Supplement. In the final meta-analysis of the four cohorts, no SNP exceeded the stringent threshold for genome-wide significance (<em>P</em> = 5 × 10<sup>−8</sup>), but rs7712513 (HR, 1.39; <em>P</em> = 2.08 × 10<sup>−7</sup>) showed a strongly suggestive <em>P</em> value and consistent HRs across all four studies, and rs7765004 (HR, 1.38; <em>P</em> = 7.09 × 10<sup>−7</sup>) was consistent in three of the four studies, with a null association in the GOELAMS-075 replication study (<a href="/pmc/articles/PMC4879713/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). Both SNPs were also strongly associated with OS, with rs7712513 (HR, 1.49; <em>P</em> = 3.53 × 10<sup>−8</sup>) reaching the genome-wide significance level. After pooling all four cohorts, these associations held in models adjusted for age, sex, aaIPI, study, and treatment, as well as in a subgroup analysis of patients only treated with R-CHOP (Data Supplement).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2.</h3><!--caption a7--><div class="caption"><p id="__p19">Associations of SNPs With Event-Free and Overall Survival in DLBCL in the First and Second Stages and Final Meta-Analysis</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140044669209136" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th rowspan="2" colspan="1" align="center">SNP and Study</th><th rowspan="2" colspan="1" align="center">Chromosome</th><th rowspan="2" colspan="1" align="center">Position</th><th rowspan="2" colspan="1" align="center">Nearest Gene</th><th colspan="2" rowspan="1" align="center">Allele<hr></th><th rowspan="2" colspan="1" align="center">RAF</th><th rowspan="2" colspan="1" align="center">No. of Patients</th><th colspan="3" rowspan="1" align="center">Event-Free Survival<hr></th><th colspan="3" rowspan="1" align="center">Overall Survival<hr></th></tr><tr><th rowspan="1" colspan="1" align="center">Risk</th><th rowspan="1" colspan="1" align="center">Other</th><th rowspan="1" colspan="1" align="center">HR<sup>*</sup></th><th rowspan="1" colspan="1" align="center">95% CI</th><th rowspan="1" colspan="1" align="center"><em>P</em></th><th rowspan="1" colspan="1" align="center">HR<sup>*</sup></th><th rowspan="1" colspan="1" align="center">95% CI</th><th rowspan="1" colspan="1" align="center"><em>P</em></th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left">rs7712513</td><td rowspan="1" colspan="1" align="center">5</td><td rowspan="1" colspan="1" align="center">121918208</td><td rowspan="1" colspan="1" align="center"><em>ARGFXP1</em></td><td rowspan="1" colspan="1" align="center">C</td><td rowspan="1" colspan="1" align="center">A</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    First stage</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">        LYSA-03B</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">0.35</td><td rowspan="1" colspan="1" align="center">540</td><td rowspan="1" colspan="1" align="center">1.40</td><td rowspan="1" colspan="1" align="center">1.14 to 1.73</td><td rowspan="1" colspan="1" align="center">.0016</td><td rowspan="1" colspan="1" align="center">1.48</td><td rowspan="1" colspan="1" align="center">1.17 to 1.89</td><td rowspan="1" colspan="1" align="center">.0013</td></tr><tr><td rowspan="1" colspan="1" align="left">        SPORE-I</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">0.34</td><td rowspan="1" colspan="1" align="center">312</td><td rowspan="1" colspan="1" align="center">1.46</td><td rowspan="1" colspan="1" align="center">1.14 to 1.88</td><td rowspan="1" colspan="1" align="center">.0028</td><td rowspan="1" colspan="1" align="center">1.63</td><td rowspan="1" colspan="1" align="center">1.23 to 2.17</td><td rowspan="1" colspan="1" align="center">.00077</td></tr><tr><td rowspan="1" colspan="1" align="left">        Meta-analysis (Discovery)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">1.43</td><td rowspan="1" colspan="1" align="center">1.21 to 1.67</td><td rowspan="1" colspan="1" align="center">1.48 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" align="center">1.54</td><td rowspan="1" colspan="1" align="center">1.28 to 1.86</td><td rowspan="1" colspan="1" align="center">3.95 × 10<sup>−6</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">    Second stage</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">        SPORE-II</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">0.31</td><td rowspan="1" colspan="1" align="center">391</td><td rowspan="1" colspan="1" align="center">1.33</td><td rowspan="1" colspan="1" align="center">1.05 to 1.68</td><td rowspan="1" colspan="1" align="center">.020</td><td rowspan="1" colspan="1" align="center">1.50</td><td rowspan="1" colspan="1" align="center">1.13 to 1.98</td><td rowspan="1" colspan="1" align="center">.0045</td></tr><tr><td rowspan="1" colspan="1" align="left">        GOELAMS-075</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">0.35</td><td rowspan="1" colspan="1" align="center">294</td><td rowspan="1" colspan="1" align="center">1.33</td><td rowspan="1" colspan="1" align="center">0.97 to 1.84</td><td rowspan="1" colspan="1" align="center">.079</td><td rowspan="1" colspan="1" align="center">1.28</td><td rowspan="1" colspan="1" align="center">0.87 to 1.88</td><td rowspan="1" colspan="1" align="center">.20</td></tr><tr><td rowspan="1" colspan="1" align="left">        Meta-analysis (all cohorts)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">1.39</td><td rowspan="1" colspan="1" align="center">1.23 to 1.57</td><td rowspan="1" colspan="1" align="center">2.08 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">1.49</td><td rowspan="1" colspan="1" align="center">1.29 to 1.72</td><td rowspan="1" colspan="1" align="center">3.53 × 10<sup>−8</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">rs7765004</td><td rowspan="1" colspan="1" align="center">6</td><td rowspan="1" colspan="1" align="center">114071720</td><td rowspan="1" colspan="1" align="center"><em>LOC100652953</em></td><td rowspan="1" colspan="1" align="center">C</td><td rowspan="1" colspan="1" align="center">A</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    First stage</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">        LYSA-03B</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">0.33</td><td rowspan="1" colspan="1" align="center">540</td><td rowspan="1" colspan="1" align="center">1.34</td><td rowspan="1" colspan="1" align="center">1.08 to 1.68</td><td rowspan="1" colspan="1" align="center">.0085</td><td rowspan="1" colspan="1" align="center">1.43</td><td rowspan="1" colspan="1" align="center">1.11 to 1.84</td><td rowspan="1" colspan="1" align="center">.0054</td></tr><tr><td rowspan="1" colspan="1" align="left">        SPORE-I</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">0.30</td><td rowspan="1" colspan="1" align="center">312</td><td rowspan="1" colspan="1" align="center">1.52</td><td rowspan="1" colspan="1" align="center">1.18 to 1.97</td><td rowspan="1" colspan="1" align="center">.0013</td><td rowspan="1" colspan="1" align="center">1.43</td><td rowspan="1" colspan="1" align="center">1.06 to 1.92</td><td rowspan="1" colspan="1" align="center">.018</td></tr><tr><td rowspan="1" colspan="1" align="left">        Meta-analysis (Discovery)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">1.42</td><td rowspan="1" colspan="1" align="center">1.20 to 1.68</td><td rowspan="1" colspan="1" align="center">4.35 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" align="center">1.43</td><td rowspan="1" colspan="1" align="center">1.18 to 1.73</td><td rowspan="1" colspan="1" align="center">2.65 × 10<sup>−4</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">    Second stage</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">        SPORE-II</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">0.30</td><td rowspan="1" colspan="1" align="center">391</td><td rowspan="1" colspan="1" align="center">1.44</td><td rowspan="1" colspan="1" align="center">1.13 to 1.84</td><td rowspan="1" colspan="1" align="center">.0030</td><td rowspan="1" colspan="1" align="center">1.87</td><td rowspan="1" colspan="1" align="center">1.39 to 2.52</td><td rowspan="1" colspan="1" align="center">4.00 × 10<sup>−5</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">        GOELAMS-075</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">0.32</td><td rowspan="1" colspan="1" align="center">294</td><td rowspan="1" colspan="1" align="center">1.14</td><td rowspan="1" colspan="1" align="center">0.80 to 1.62</td><td rowspan="1" colspan="1" align="center">.48</td><td rowspan="1" colspan="1" align="center">1.04</td><td rowspan="1" colspan="1" align="center">0.68 to 1.60</td><td rowspan="1" colspan="1" align="center">.86</td></tr><tr><td rowspan="1" colspan="1" align="left">        Meta-analysis (all cohorts)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">1.38</td><td rowspan="1" colspan="1" align="center">1.22 to 1.57</td><td rowspan="1" colspan="1" align="center">7.09 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">1.47</td><td rowspan="1" colspan="1" align="center">1.27 to 1.71</td><td rowspan="1" colspan="1" align="center">5.36 × 10<sup>−7</sup></td></tr></tbody></table></div><div id="largeobj_idm140044669209136" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4879713/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140044669657488"><p id="__p20" class="p p-first-last">Abbreviations: DLBCL, diffuse large B-cell lymphoma; GOELAMS, Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang; HR, hazard ratio; LYSA, Lymphoma Study Association; RAF, risk allele frequency; SNP, single nucleotide polymorphism; SPORE, Specialized Program of Research Excellence.</p></div><div id="TF2-1"><sup>*</sup>HR and 95% CIs adjusted for age, sex, and age-adjusted International Prognostic Index.</div></div></div><p id="__p22" class="p">The SNP rs7712513 localizes to 5q23.2, which is near the pseudogene <em>ARGFXP1</em> (arginine-fifty homeobox pseudogene 1) as well as <em>SNCAIP</em> (synuclein, α interacting protein) and <em>SNX2</em> (sorting nexin 2; <a href="/pmc/articles/PMC4879713/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig 1</span></a>A). rs7765004 localizes to 6q21, where <em>MARCKS</em> (gene encoding myristoylated alanine-rich protein kinase C substrate) and <em>HDAC2</em> (gene encoding histone deacetylase 2) are located (<a href="/pmc/articles/PMC4879713/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig 1</span></a>B).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC4879713/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140044669110464" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is zlj9991056540001.jpg" title="An external file that holds a picture, illustration, etc.
Object name is zlj9991056540001.jpg" src="/pmc/articles/PMC4879713/bin/zlj9991056540001.jpg"></div></a><div id="largeobj_idm140044669110464" class="largeobj-link align_right" style=""><a href="/pmc/articles/PMC4879713/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a target="object" href="/pmc/articles/PMC4879713/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC4879713/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Fig 1.</a></div><!--caption a7--><div class="caption"><p id="__p23">Association results, recombination hotspots, and linkage disequilibrium plots for the regions associated with event-free survival in diffuse large B-cell lymphoma in the discovery cohort. (A) 5q21. (B) 6q21.</p></div></div></div></div><div id="__sec13" class="sec"><h3 id="__sec13title">Cell of Origin</h3><p id="__p24" class="p p-first-last">In 695 patients with data on cell of origin, the associations for rs7712513 were similar for GCB DLBCL (HR, 1.38; 95% CI, 1.09 to 1.77; <em>P</em> = .0089) compared with non-GCB DLBCL (HR, 1.49; 95% CI, 1.15 to 1.93; <em>P</em> = .0029); the associations for rs7765004 were also similar for GCB DLBCL (HR, 1.30; 95% CI, 1.00 to 1.70; <em>P</em> = .053) and non-GCB DLBCL (HR, 1.19; 95% CI, 0.90 to 1.58; <em>P</em> = .21).</p></div><div id="__sec14" class="sec"><h3 id="__sec14title">Multi-SNP Risk Score for EFS</h3><p id="__p25" class="p p-first">In the pooled data set, we constructed a risk score based on the number of deleterious alleles from rs7712513 and rs7765004, which was strongly associated with EFS (<em>P</em> = 1.78 × 10<sup>−12</sup>; <a href="/pmc/articles/PMC4879713/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig 2</span></a>A). Compared with no deleterious alleles, patients with one (HR, 1.23; 95% CI, 0.95 to 1.59), two (HR, 1.72; 95% CI, 1.32 to 2.23), or three or more (HR, 2.76; 95% CI, 2.03 to 3.73) deleterious alleles had inferior EFS, adjusted for age, sex, aaIPI, study, and treatment (Data Supplement). The c-statistic was 0.666 for the model with age, sex, aaIPI, study, and treatment, and the c-statistic was 0.689 after addition of the two-SNP risk score. In analyses stratified on aaIPI, the SNP score was associated with EFS for low-risk patients with DLBCL (score, 0 to 1; <em>P</em> = .02) and high-risk patients with DLBCL (score, 2 to 3; <em>P</em> = 1.09 × 10<sup>−11</sup>; <a href="/pmc/articles/PMC4879713/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figs 2</span></a>B and <a href="/pmc/articles/PMC4879713/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -1.5em;">and2C).</span></span><span>2</span></a>C). The two-SNP risk score also predicted EFS in both GCB (<em>P</em> = .001) and non-GCB (<em>P</em> = .0009) DLBCL (Data Supplement). No interactions were observed between multi-SNP risk score and aaIPI (<em>P</em> = .08) or cell of origin (<em>P</em> = .68) on EFS.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC4879713/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140044666840512" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is zlj9991056540002.jpg" title="An external file that holds a picture, illustration, etc.
Object name is zlj9991056540002.jpg" src="/pmc/articles/PMC4879713/bin/zlj9991056540002.jpg"></div></a><div id="largeobj_idm140044666840512" class="largeobj-link align_right" style=""><a href="/pmc/articles/PMC4879713/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a target="object" href="/pmc/articles/PMC4879713/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC4879713/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Fig 2.</a></div><!--caption a7--><div class="caption"><p id="__p26">Multi–single nucleotide polymorphism (SNP) risk score for event-free survival; pooled analysis of all four cohorts. (A) All patients (N = 1,537). (B) Patients with low-risk age-adjusted International Prognostic Index (aaIPI; score 0 to 1; n = 801). (C) Patients with high-risk aaIPI (score 2 to 3; n = 736). <em>P</em> values shown are from the Cox proportional hazard models adjusted for age, sex, aaIPI (when not stratified on this value), and treatment regimen.</p></div></div></div></div><div id="__sec15" class="sec"><h3 id="__sec15title">Correlation Between SNP Genotyping and Tumor Gene Expression</h3><p id="__p27" class="p p-first-last">The SNPs at 5q23.2 and 6q21 are noncoding variants. To investigate possible functional consequences of these SNPs on nearby genes, we correlated the two sentinel SNPs with all probe sets annotated to a gene located within 500 kb of the SNP using tumor gene expression data from an Affymetrix U133 plus 2.0 experiment (Affymetrix, Santa Clara, CA) conducted using 73 patients from the LYSA-03B study (Data Supplement). A differential expression between the three genotypes of rs7712513 was observed for the following three genes of unknown function in the National Center for Biotechnology Information database: <em>MGC32805</em> or <em>LOC153163</em> (<em>P</em> = .013), <em>PPIC</em> or <em>LOC101927357</em> (<em>P</em> = .014), and <em>LOC100505841</em> (<em>P</em> = .034). We also found differential expression between the three genotypes of rs7765004 for the <em>LOC101927794</em> (<em>P</em> = .037) and <em>HDAC2</em> genes (<em>P</em> = .045); for the latter gene, there was significantly higher expression in the tumors from patients with the AA + AC genotype compared with the CC genotype (<em>P</em> = .020; Data Supplement).</p></div><div id="__sec16" class="sec sec-last"><h3 id="__sec16title">Additional Bioinformatics Analyses</h3><p id="__p28" class="p p-first-last">All variant positions in linkage disequilibrium (LD) (r<sup>2</sup> ≥ 0.7) with rs7765004 on chromosome 6 (n = 20) and rs7712513 on chromosome 5 (n = 1) were identified (Data Supplement). One SNP in LD with rs7765004 is located in an evolutionarily conserved region, suggesting regulatory potential. More interestingly, both rs7765004 and another SNP in LD with rs7765004 (rs6923574) are <em>cis</em>-expression quantitative trait loci (eQTL) eSNPs regulating expression of <em>MARCKS</em> according to the lymphoblastoid cell line eQTL data set.<sup><a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996568">23</a></sup> In addition, all SNPs in LD with rs7765004 are located within the peak regions of the histone marker ChIP-Seq data in the B-lymphocyte cell line GM12878 according to ENCODE (Encyclopedia of DNA Elements; <a href="https://www.encodeproject.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://www.encodeproject.org</a>). No functional roles for rs7712513 were identified using these bioinformatics approaches.</p></div></div><div id="__sec17" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec17title">DISCUSSION</h2><p id="__p29" class="p p-first">In this GWAS of prognosis in patients with DLBCL initially treated with immunochemotherapy regimens (the first of its kind, to our knowledge), we identified two loci that were suggestive of association with EFS and OS independent of IPI. A risk score constructed with these two loci showed a modest improvement in predictive ability over clinical characteristics (age, sex, aaIPI, and treatment) alone (c-statistic, 0.689 <em>v</em> 0.666, respectively). Potentially of more clinical significance, our two-SNP risk score identified patients with diverse outcomes within traditional low-risk (aaIPI of 0 to 1) and high-risk (aaIPI of 2 to 3) DLBCL patient groups and, in particular, identified a group of high-risk patients (aaIPI of 2 to 3) with three or more deleterious alleles who had a particularly poor prognosis (<a href="/pmc/articles/PMC4879713/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig 2</span></a>C).</p><p id="__p30">More fundamentally, our data are encouraging for the role of host genetic background on DLBCL prognosis, which can provide novel leads into lymphoma biology and perhaps new therapeutic targets. This concept was suggested by retrospective studies mainly conducted before the rituximab era and that used a candidate gene approach, with SNPs in immune genes,<sup><a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996584">4</a>–<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996570">7</a>,<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996588">10</a></sup> DNA repair and metabolism genes,<sup><a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996560">8</a>,<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996557">9</a>,<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996572">24</a></sup> and angiogenesis genes<sup><a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996586">25</a></sup> associated with outcome in patients with DLBCL. We explored the significant SNPs for DLBCL outcome from these studies in the first-stage meta-analysis and did not find any that approached conventional significance (Data Supplement).</p><p id="__p31">The SNP at 5q23.2 (rs7712513) maps near two genes, <em>SNCAIP</em> and <em>SNX2</em> (<a href="/pmc/articles/PMC4879713/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig 1</span></a>A), implicated in pathogenic protein inclusions<sup><a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996573">26</a></sup> and cellular trafficking proteins,<sup><a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996577">27</a></sup> respectively. Tandem duplication of <em>SNCAIP</em> has been found in medulloblastoma,<sup><a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996556">28</a></sup> and one synphilin-1 partner, synuclein, was recently found to be implicated in B-cell development.<sup><a href="#B29" rid="B29" class=" bibr popnode">29</a></sup>
<em>SNX2</em> has been identified as a fusion partner of <em>ABL1</em> in B-cell acute lymphoblastic leukemia,<sup><a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996578">30</a></sup> and as a member of membrane trafficking, <em>SNX2</em> was found to interact with the receptors of platelet-derived growth factor or epidermal growth factor and could modulate target-drug sensitivity.<sup><a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996582">27</a>,<a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996567">31</a></sup> However, we found no correlation between rs7712513 genotypes and either <em>SNCAIP</em> or <em>SNX2</em> expression in DLBCL tumors (Data Supplement), and bioinformatics approaches did not identify any functional links to this SNP.</p><p id="__p32">The SNP rs7765004 at 6q21 maps near the <em>MARCKS</em> and <em>HDAC2</em> encoding genes (<a href="/pmc/articles/PMC4879713/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig 1</span></a>B). <em>MARCKS</em> is a substrate for protein kinase C and has been implicated in the modulation of the metastatic phenotype in a colon carcinoma model,<sup><a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996564">32</a></sup> but a role of <em>MARCKS</em> in lymphoma pathogenesis has not been reported. Both rs7765004 and another SNP on chromosome 6, rs6923574, are SNPs regulating expression of <em>MARCKS</em> according to the eQTL data from HapMap human lymphoblastoid cell lines. <em>MARCKS</em> plays important roles in cell shape, cell motility, secretion, transmembrane transport, and regulation of the cell cycle. Recently, <em>MARCKS</em> has been implicated in the exocytosis of a number of vesicles and granules such as mucin and chromaffin.<sup><a href="#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996581">33</a>–<a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996566">35</a></sup> The search of the seeQTL database did not show an association of rs7765004 genotypes with <em>HDAC2</em> expression, although <em>HDAC2</em> has previously been found to be overexpressed in DLBCL.<sup><a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996579">36</a>,<a href="#B37" rid="B37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996583">37</a></sup> Perhaps unexpectedly, in our own gene expression data, we observed lower expression of <em>HDAC2</em> in DLBCL tumors with the germline CC genotype compared with AA + AC genotype (<em>P</em> = .020; Data Supplement), suggesting that the risk allele (C) associated with poorer EFS and OS is also associated with lower <em>HDAC</em> expression by DLBCL tumors. Further functional work is needed to better interrogate this region.</p><p id="__p33">Strengths of this study include the use of two independent first-stage cohorts combined with additional independent cohorts in the second stage, all with detailed and prospectively acquired clinical and outcome data. Further advantages include use of both observational and randomized clinical trial study designs and the fact that all treatments were based on immunochemotherapy regimens, enhancing generalizability. Sensitivity analysis suggested minimal impact of the type of immunochemotherapy used. A potential limitation was that one of the second-stage cohorts (GOELAMS-075) had more unique clinical characteristics, restricting patients to age ≤ 60 years. Our primary EFS end point results did not reach the stringent GWAS threshold for statistical significance of <em>P</em> &lt; 5 × 10<sup>−8</sup>. We were only powered to detect effect sizes as small as 1.75 assuming minor allele frequency of 30% or higher with 80% power. However, given the consistency of effect sizes across the cohorts, a statistical significance that was just less than the stringent GWAS statistical threshold, and biologic plausibility, our results suggest true findings rather than false-negative results. Although our approach seems to be promising, in the future, even larger studies will be required to identify additional loci.</p><p id="__p34">From a therapeutic perspective, we recognize that our results cannot immediately lead to proposing targeted agents, but the identification of an SNP modulating <em>HDAC</em> expression emphasizes again the role of epigenetics in the biology of DLBCL, but now at the host germline level as well, and perhaps, in the future, this may help to choose patients in which epigenetic modifiers might be more efficient. The other locus draws attention to cellular trafficking pathways that might be targetable if additional work confirms the importance of these pathways in DLBCL, considering the recent example of selective inhibition of nuclear export.<sup><a href="#B38" rid="B38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_534996571">38</a></sup></p><p id="__p35" class="p p-last">In summary, our GWAS provides encouraging evidence for germline susceptibility loci of prognostic impact in patients with DLBCL treated with immunochemotherapy. These data further suggest the contribution of inherited genetic background to the clinical behavior of lymphoma. The assessment of the allelic status of these novel germline SNPs offers promise as a prognostic marker and a new approach to uncovering novel biology.</p></div><div id="__sec18" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec18title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="PMC_1">

<!--caption a9--><strong>Data Supplement:</strong>

<div class="sup-box half_rhythm" id="idm140044742916144"><a href="/pmc/articles/PMC4879713/bin/supp_33_33_3930__index.html" data-ga-action="click_feat_suppl">Click here to view.</a></div>

</div></div><div id="idm140044742909296" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140044742909296title">Acknowledgment</h2><div class="sec"><p id="__p38">We thank Anne-Laure Borrel and Aurelie Verney for their technical support; Catherine Maingonnat, Philippe Bertrand, and Elodie Bohers for the genotyping experiments in the Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang (GOELAMS) cohort; and all the Lymphoma Study Association (LYSA) and Molecular Epidemiology Resource (MER) staff for data collection. We thank Sondra Buehler for editorial assistance. We thank Diana Zelenika, PhD, for genotyping of the Groupe d'Etude des Lymphomes de l'Adulte samples.</p></div></div><div id="idm140044742912608" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140044742912608title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140044742912480"></p><p id="__p36" class="p p-first-last">Supported by National Cancer Institute Specialized Programs of Research Excellence (SPORE) in Human Cancer (Grant No. P50 CA97274), Molecular Epidemiology of Non-Hodgkin Lymphoma Survival (Grant No. R01 CA129539), National Center for Advancing Translational Science (Grant No. UL1 TR000135), Henry J. Predolin Foundation, Institut National du Cancer (INCa, PAIR Lymphome, 2008-020), Lymphoma Study Association, Fondation de France, and Philippe Foundation.</p><p></p><p class="fn sec" id="idm140044742911136"> </p><p id="__p37" class="p p-first-last">Authors' disclosures of potential conflicts of interest are found in the article online at <a href="http://www.jco.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.jco.org</a>. Author contributions are found at the end of this article.</p><p></p></div></div><div id="__sec19" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec19title">AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST</h2><!--/article/back/sec/--><p id="__p39" class="p p-first-last">Disclosures provided by the authors are available with this article at <a href="http://www.jco.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.jco.org</a>.</p></div><div id="__sec20" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec20title">AUTHOR CONTRIBUTIONS</h2><!--/article/back/sec/--><p id="__p40" class="p p-first"><strong>Conception and design:</strong> Hervé Ghesquieres, Matthew J. Maurer, Gilles A. Salles, James R. Cerhan</p><p id="__p41"><strong>Financial support:</strong> Gilles A. Salles, James R. Cerhan</p><p id="__p42"><strong>Administrative support:</strong> Gilles A. Salles, James R. Cerhan</p><p id="__p43"><strong>Provision of study materials or patients:</strong> Amelie S. Veron, Thierry Fest, Thomas M. Habermann, Marie C. Bene, Sylvain Mareschal, Corinne Haioun, Thierry Lamy, Stephen M. Ansell, Herve Tilly, Thomas E. Witzig, George J. Weiner, Andrew L. Feldman, Ahmet Dogan, Thierry Jo Molina, Brian K. Link, Noel Milpied, Gilles A. Salles</p><p id="__p44"><strong>Collection and assembly of data:</strong> Hervé Ghesquieres, Susan L. Slager, Fabrice Jardin, Amelie S. Veron, Matthew J. Maurer, Thierry Fest, Thomas M. Habermann, Marie C. Bene, Anne J. Novak, Sylvain Mareschal, Corinne Haioun, Thierry Lamy, Stephen M. Ansell, Herve Tilly, Thomas E. Witzig, George J. Weiner, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, Thierry Jo Molina, Brian K. Link, Noel Milpied, David G. Cox, Gilles A. Salles, James R. Cerhan</p><p id="__p45"><strong>Data analysis and interpretation:</strong> Hervé Ghesquieres, Susan L. Slager, Yan W. Asmann, Matthew J. Maurer, Curtis L. Olswold, David G. Cox, Gilles A. Salles, James R. Cerhan</p><p id="__p46"><strong>Manuscript writing:</strong> All authors</p><p id="__p47" class="p p-last"><strong>Final approval of manuscript:</strong> All authors</p></div><div id="__sec21" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec21title">AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST</h2><!--/article/back/sec/--><div id="__sec22" class="sec sec-first"><h3 id="__sec22title">Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy</h3><p id="__p48" class="p p-first-last"><em>The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to <a href="http://www.asco.org/rwc" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.asco.org/rwc</a> or <a href="http://jco.ascopubs.org/site/ifc" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">jco.ascopubs.org/site/ifc</a></em>.</p></div><div id="__sec23" class="sec"><h3 id="__sec23title">Hervé Ghesquieres</h3><p id="__p49" class="p p-first-last">No relationship to disclose</p></div><div id="__sec24" class="sec"><h3 id="__sec24title">Susan L. Slager</h3><p id="__p50" class="p p-first-last">No relationship to disclose</p></div><div id="__sec25" class="sec"><h3 id="__sec25title">Fabrice Jardin</h3><p id="__p51" class="p p-first-last">No relationship to disclose</p></div><div id="__sec26" class="sec"><h3 id="__sec26title">Amelie S. Veron</h3><p id="__p52" class="p p-first-last">No relationship to disclose</p></div><div id="__sec27" class="sec"><h3 id="__sec27title">Yan W. Asmann</h3><p id="__p53" class="p p-first-last">No relationship to disclose</p></div><div id="__sec28" class="sec"><h3 id="__sec28title">Matthew J. Maurer</h3><p id="__p54" class="p p-first-last">No relationship to disclose</p></div><div id="__sec29" class="sec"><h3 id="__sec29title">Thierry Fest</h3><p id="__p55" class="p p-first-last">No relationship to disclose</p></div><div id="__sec30" class="sec"><h3 id="__sec30title">Thomas M. Habermann</h3><p id="__p56" class="p p-first-last">No relationship to disclose</p></div><div id="__sec31" class="sec"><h3 id="__sec31title">Marie C. Bene</h3><p id="__p57" class="p p-first"><strong>Research Funding:</strong> Beckman Coulter, sponsoring of Harmonemia Project</p><p id="__p58" class="p p-last"><strong>Travel, Accommodations, Expenses:</strong> Celgene, American Society of Hematology Meeting</p></div><div id="__sec32" class="sec"><h3 id="__sec32title">Anne J. Novak</h3><p id="__p59" class="p p-first-last">No relationship to disclose</p></div><div id="__sec33" class="sec"><h3 id="__sec33title">Sylvain Mareschal</h3><p id="__p60" class="p p-first-last">No relationship to disclose</p></div><div id="__sec34" class="sec"><h3 id="__sec34title">Corinne Haioun</h3><p id="__p61" class="p p-first-last">No relationship to disclose</p></div><div id="__sec35" class="sec"><h3 id="__sec35title">Thierry Lamy</h3><p id="__p62" class="p p-first-last">No relationship to disclose</p></div><div id="__sec36" class="sec"><h3 id="__sec36title">Stephen M. Ansell</h3><p id="__p63" class="p p-first"><strong>Consulting or Advisory Role:</strong> Research to Practice</p><p id="__p64" class="p p-last"><strong>Research Funding:</strong> Bristol-Myers Squibb, Celldex, Seattle Genetics</p></div><div id="__sec37" class="sec"><h3 id="__sec37title">Herve Tilly</h3><p id="__p65" class="p p-first"><strong>Honoraria:</strong> Celgene, Roche/Genentech, Janssen Pharmaceuticals</p><p id="__p66"><strong>Consulting or Advisory Role:</strong> Takeda, Immunogen</p><p id="__p67"><strong>Research Funding:</strong> Celgene (Inst)</p><p id="__p68" class="p p-last"><strong>Travel, Accommodations, Expenses:</strong> Roche</p></div><div id="__sec38" class="sec"><h3 id="__sec38title">Thomas E. Witzig</h3><p id="__p69" class="p p-first"><strong>Stock or Other Ownership:</strong> Valeant Pharmaceuticals International</p><p id="__p70"><strong>Consulting or Advisory Role:</strong> Amgen</p><p id="__p71" class="p p-last"><strong>Research Funding:</strong> Celgene (Inst), Novartis (Inst), Spectrum Pharmaceuticals (Inst), Acerta Pharma (Inst)</p></div><div id="__sec39" class="sec"><h3 id="__sec39title">George J. Weiner</h3><p id="__p72" class="p p-first-last">No relationship to disclose</p></div><div id="__sec40" class="sec"><h3 id="__sec40title">Andrew L. Feldman</h3><p id="__p73" class="p p-first-last">No relationship to disclose</p></div><div id="__sec41" class="sec"><h3 id="__sec41title">Ahmet Dogan</h3><p id="__p74" class="p p-first-last">No relationship to disclose</p></div><div id="__sec42" class="sec"><h3 id="__sec42title">Julie M. Cunningham</h3><p id="__p75" class="p p-first-last">No relationship to disclose</p></div><div id="__sec43" class="sec"><h3 id="__sec43title">Curtis L. Olswold</h3><p id="__p76" class="p p-first-last">No relationship to disclose</p></div><div id="__sec44" class="sec"><h3 id="__sec44title">Thierry Jo Molina</h3><p id="__p77" class="p p-first"><strong>Honoraria:</strong> Merck Serono</p><p id="__p78" class="p p-last"><strong>Travel, Accommodations, Expenses:</strong> Mundipharma, Gilead Sciences</p></div><div id="__sec45" class="sec"><h3 id="__sec45title">Brian K. Link</h3><p id="__p79" class="p p-first"><strong>Consulting or Advisory Role:</strong> Genentech/Roche, Abbvie, Gilead Sciences, Pharmacyclics</p><p id="__p80"><strong>Research Funding:</strong> Genentech/Roche (Inst), Millennium Takeda (Inst), Bristol-Myers Squibb (Inst), Seattle Cancer Care Alliance (Inst), Pharmacyclics (Inst)</p><p id="__p81" class="p p-last"><strong>Travel, Accommodations, Expenses:</strong> Genentech/Roche, Gilead Sciences</p></div><div id="__sec46" class="sec"><h3 id="__sec46title">Noel Milpied</h3><p id="__p82" class="p p-first-last">No relationship to disclose</p></div><div id="__sec47" class="sec"><h3 id="__sec47title">David G. Cox</h3><p id="__p83" class="p p-first"><strong>Honoraria:</strong> Genomic Health</p><p id="__p84" class="p p-last"><strong>Patents, Royalties, Other Intellectual Property:</strong> Patent EP2764365A1</p></div><div id="__sec48" class="sec"><h3 id="__sec48title">Gilles A. Salles</h3><p id="__p85" class="p p-first"><strong>Honoraria:</strong> Roche/Genentech, Mundipharma, Janssen, Celgene</p><p id="__p86"><strong>Consulting or Advisory Role:</strong> Roche/Genentech, Gilead Sciences, Janssen Pharmaceuticals, Celgene, Amgen</p><p id="__p87"><strong>Research Funding:</strong> Roche/Genentech (Inst)</p><p id="__p88" class="p p-last"><strong>Travel, Accommodations, Expenses:</strong> Roche/Genentech</p></div><div id="__sec49" class="sec sec-last"><h3 id="__sec49title">James R. Cerhan</h3><p id="__p89" class="p p-first-last">No relationship to disclose</p></div></div><div id="idm140044670775584" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140044670775584title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="element-citation">Roschewski M, Staudt LM, Wilson WH. Diffuse large B-cell lymphoma-treatment approaches in the molecular era. <span><span class="ref-journal">Nat Rev Clin Oncol. </span>2014;<span class="ref-vol">11</span>:12–23.</span> [<a href="/pubmed/24217204" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Clin+Oncol&amp;title=Diffuse+large+B-cell+lymphoma-treatment+approaches+in+the+molecular+era&amp;author=M+Roschewski&amp;author=LM+Staudt&amp;author=WH+Wilson&amp;volume=11&amp;publication_year=2014&amp;pages=12-23&amp;pmid=24217204&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="element-citation">Shipp MA, Harrington DP, Anderson JR, et al.  A predictive model for aggressive non-Hodgkin's lymphoma: The International Non-Hodgkin's Lymphoma Prognostic Factors Project. <span><span class="ref-journal">N Engl J Med. </span>1993;<span class="ref-vol">329</span>:987–994.</span> [<a href="/pubmed/8141877" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+predictive+model+for+aggressive+non-Hodgkin's+lymphoma:+The+International+Non-Hodgkin's+Lymphoma+Prognostic+Factors+Project&amp;author=MA+Shipp&amp;author=DP+Harrington&amp;author=JR+Anderson&amp;volume=329&amp;publication_year=1993&amp;pages=987-994&amp;pmid=8141877&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="element-citation">Lenz G, Staudt LM. Aggressive lymphomas. <span><span class="ref-journal">N Engl J Med. </span>2010;<span class="ref-vol">362</span>:1417–1429.</span> [<a href="/pubmed/20393178" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Aggressive+lymphomas&amp;author=G+Lenz&amp;author=LM+Staudt&amp;volume=362&amp;publication_year=2010&amp;pages=1417-1429&amp;pmid=20393178&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="element-citation">Aschebrook-Kilfoy B, Zheng T, Foss F, et al.  Polymorphisms in immune function genes and non-Hodgkin lymphoma survival. <span><span class="ref-journal">J Cancer Surviv. </span>2012;<span class="ref-vol">6</span>:102–114.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3326600/">PMC free article</a>]</span> [<a href="/pubmed/22113576" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cancer+Surviv&amp;title=Polymorphisms+in+immune+function+genes+and+non-Hodgkin+lymphoma+survival&amp;author=B+Aschebrook-Kilfoy&amp;author=T+Zheng&amp;author=F+Foss&amp;volume=6&amp;publication_year=2012&amp;pages=102-114&amp;pmid=22113576&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="element-citation">Charbonneau B, Maurer MJ, Fredericksen ZS, et al.  Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma. <span><span class="ref-journal">Am J Hematol. </span>2012;<span class="ref-vol">87</span>:880–885.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3586263/">PMC free article</a>]</span> [<a href="/pubmed/22718493" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hematol&amp;title=Germline+variation+in+complement+genes+and+event-free+survival+in+follicular+and+diffuse+large+B-cell+lymphoma&amp;author=B+Charbonneau&amp;author=MJ+Maurer&amp;author=ZS+Fredericksen&amp;volume=87&amp;publication_year=2012&amp;pages=880-885&amp;pmid=22718493&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="element-citation">Habermann TM, Wang SS, Maurer MJ, et al.  Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. <span><span class="ref-journal">Blood. </span>2008;<span class="ref-vol">112</span>:2694–2702.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2556607/">PMC free article</a>]</span> [<a href="/pubmed/18633131" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Host+immune+gene+polymorphisms+in+combination+with+clinical+and+demographic+factors+predict+late+survival+in+diffuse+large+B-cell+lymphoma+patients+in+the+pre-rituximab+era&amp;author=TM+Habermann&amp;author=SS+Wang&amp;author=MJ+Maurer&amp;volume=112&amp;publication_year=2008&amp;pages=2694-2702&amp;pmid=18633131&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="element-citation">Lech-Maranda E, Baseggio L, Bienvenu J, et al.  Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. <span><span class="ref-journal">Blood. </span>2004;<span class="ref-vol">103</span>:3529–3534.</span> [<a href="/pubmed/14701701" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Interleukin-10+gene+promoter+polymorphisms+influence+the+clinical+outcome+of+diffuse+large+B-cell+lymphoma&amp;author=E+Lech-Maranda&amp;author=L+Baseggio&amp;author=J+Bienvenu&amp;volume=103&amp;publication_year=2004&amp;pages=3529-3534&amp;pmid=14701701&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="element-citation">Rossi D, Rasi S, Di Rocco A, et al.  The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma. <span><span class="ref-journal">Blood. </span>2011;<span class="ref-vol">117</span>:2405–2413.</span> [<a href="/pubmed/21156845" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=The+host+genetic+background+of+DNA+repair+mechanisms+is+an+independent+predictor+of+survival+in+diffuse+large+B-cell+lymphoma&amp;author=D+Rossi&amp;author=S+Rasi&amp;author=A+Di+Rocco&amp;volume=117&amp;publication_year=2011&amp;pages=2405-2413&amp;pmid=21156845&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="element-citation">Wang SS, Maurer MJ, Morton LM, et al.  Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. <span><span class="ref-journal">Leukemia. </span>2009;<span class="ref-vol">23</span>:596–602.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3066015/">PMC free article</a>]</span> [<a href="/pubmed/18830263" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Polymorphisms+in+DNA+repair+and+one-carbon+metabolism+genes+and+overall+survival+in+diffuse+large+B-cell+lymphoma+and+follicular+lymphoma&amp;author=SS+Wang&amp;author=MJ+Maurer&amp;author=LM+Morton&amp;volume=23&amp;publication_year=2009&amp;pages=596-602&amp;pmid=18830263&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="element-citation">Warzocha K, Ribeiro P, Bienvenu J, et al.  Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. <span><span class="ref-journal">Blood. </span>1998;<span class="ref-vol">91</span>:3574–3581.</span> [<a href="/pubmed/9572991" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Genetic+polymorphisms+in+the+tumor+necrosis+factor+locus+influence+non-Hodgkin's+lymphoma+outcome&amp;author=K+Warzocha&amp;author=P+Ribeiro&amp;author=J+Bienvenu&amp;volume=91&amp;publication_year=1998&amp;pages=3574-3581&amp;pmid=9572991&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="element-citation">Delarue R, Tilly H, Mounier N, et al.  Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): A randomised phase 3 trial. <span><span class="ref-journal">Lancet Oncol. </span>2013;<span class="ref-vol">14</span>:525–533.</span> [<a href="/pubmed/23578722" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Oncol&amp;title=Dose-dense+rituximab-CHOP+compared+with+standard+rituximab-CHOP+in+elderly+patients+with+diffuse+large+B-cell+lymphoma+(the+LNH03-6B+study):+A+randomised+phase+3+trial&amp;author=R+Delarue&amp;author=H+Tilly&amp;author=N+Mounier&amp;volume=14&amp;publication_year=2013&amp;pages=525-533&amp;pmid=23578722&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="element-citation">Fitoussi O, Belhadj K, Mounier N, et al.  Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA. <span><span class="ref-journal">Haematologica. </span>2011;<span class="ref-vol">96</span>:1136–1143.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3148907/">PMC free article</a>]</span> [<a href="/pubmed/21546499" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Haematologica&amp;title=Survival+impact+of+rituximab+combined+with+ACVBP+and+upfront+consolidation+autotransplantation+in+high-risk+diffuse+large+B-cell+lymphoma+for+GELA&amp;author=O+Fitoussi&amp;author=K+Belhadj&amp;author=N+Mounier&amp;volume=96&amp;publication_year=2011&amp;pages=1136-1143&amp;pmid=21546499&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="element-citation">Ketterer N, Coiffier B, Thieblemont C, et al.  Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B) <span><span class="ref-journal">Ann Oncol. </span>2013;<span class="ref-vol">24</span>:1032–1037.</span> [<a href="/pubmed/23235801" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Oncol&amp;title=Phase+III+study+of+ACVBP+versus+ACVBP+plus+rituximab+for+patients+with+localized+low-risk+diffuse+large+B-cell+lymphoma+(LNH03-1B)&amp;author=N+Ketterer&amp;author=B+Coiffier&amp;author=C+Thieblemont&amp;volume=24&amp;publication_year=2013&amp;pages=1032-1037&amp;pmid=23235801&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="element-citation">Peyrade F, Jardin F, Thieblemont C, et al.  Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: A multicentre, single-arm, phase 2 trial. <span><span class="ref-journal">Lancet Oncol. </span>2011;<span class="ref-vol">12</span>:460–468.</span> [<a href="/pubmed/21482186" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Oncol&amp;title=Attenuated+immunochemotherapy+regimen+(R-miniCHOP)+in+elderly+patients+older+than+80+years+with+diffuse+large+B-cell+lymphoma:+A+multicentre,+single-arm,+phase+2+trial&amp;author=F+Peyrade&amp;author=F+Jardin&amp;author=C+Thieblemont&amp;volume=12&amp;publication_year=2011&amp;pages=460-468&amp;pmid=21482186&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="element-citation">Récher C, Coiffier B, Haioun C, et al.  Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): An open-label randomised phase 3 trial. <span><span class="ref-journal">Lancet. </span>2011;<span class="ref-vol">378</span>:1858–1867.</span> [<a href="/pubmed/22118442" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Intensified+chemotherapy+with+ACVBP+plus+rituximab+versus+standard+CHOP+plus+rituximab+for+the+treatment+of+diffuse+large+B-cell+lymphoma+(LNH03-2B):+An+open-label+randomised+phase+3+trial&amp;author=C+Récher&amp;author=B+Coiffier&amp;author=C+Haioun&amp;volume=378&amp;publication_year=2011&amp;pages=1858-1867&amp;pmid=22118442&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="element-citation">Drake MT, Maurer MJ, Link BK, et al.  Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. <span><span class="ref-journal">J Clin Oncol. </span>2010;<span class="ref-vol">28</span>:4191–4198.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2953973/">PMC free article</a>]</span> [<a href="/pubmed/20713849" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Vitamin+D+insufficiency+and+prognosis+in+non-Hodgkin's+lymphoma&amp;author=MT+Drake&amp;author=MJ+Maurer&amp;author=BK+Link&amp;volume=28&amp;publication_year=2010&amp;pages=4191-4198&amp;pmid=20713849&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="element-citation">Milpied NJ, Legouill S, Lamy T, et al.  No benefit of first-line rituximab (R) high-dose therapy (R-HDT) over R-CHOP14 for young adults with diffuse large B-cell lymphoma: Preliminary results of the GOELAMS 075 prospective multicentre randomized trial. <span><span class="ref-journal">Blood. </span>2010;<span class="ref-vol">116</span>:685.</span> (abstr) <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=No+benefit+of+first-line+rituximab+(R)+high-dose+therapy+(R-HDT)+over+R-CHOP14+for+young+adults+with+diffuse+large+B-cell+lymphoma:+Preliminary+results+of+the+GOELAMS+075+prospective+multicentre+randomized+trial&amp;author=NJ+Milpied&amp;author=S+Legouill&amp;author=T+Lamy&amp;volume=116&amp;publication_year=2010&amp;pages=685&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="element-citation">Hans CP, Weisenburger DD, Greiner TC, et al.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. <span><span class="ref-journal">Blood. </span>2004;<span class="ref-vol">103</span>:275–282.</span> [<a href="/pubmed/14504078" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Confirmation+of+the+molecular+classification+of+diffuse+large+B-cell+lymphoma+by+immunohistochemistry+using+a+tissue+microarray&amp;author=CP+Hans&amp;author=DD+Weisenburger&amp;author=TC+Greiner&amp;volume=103&amp;publication_year=2004&amp;pages=275-282&amp;pmid=14504078&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="element-citation">Skol AD, Scott LJ, Abecasis GR, et al.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:209–213.</span> [<a href="/pubmed/16415888" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Joint+analysis+is+more+efficient+than+replication-based+analysis+for+two-stage+genome-wide+association+studies&amp;author=AD+Skol&amp;author=LJ+Scott&amp;author=GR+Abecasis&amp;volume=38&amp;publication_year=2006&amp;pages=209-213&amp;pmid=16415888&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="element-citation">Tierney JF, Stewart LA, Ghersi D, et al.  Practical methods for incorporating summary time-to-event data into meta-analysis. <span><span class="ref-journal">Trials. </span>2007;<span class="ref-vol">8</span>:16.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1920534/">PMC free article</a>]</span> [<a href="/pubmed/17555582" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trials&amp;title=Practical+methods+for+incorporating+summary+time-to-event+data+into+meta-analysis&amp;author=JF+Tierney&amp;author=LA+Stewart&amp;author=D+Ghersi&amp;volume=8&amp;publication_year=2007&amp;pages=16&amp;pmid=17555582&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="element-citation">Willer CJ, Li Y, Abecasis GR. METAL: Fast and efficient meta-analysis of genomewide association scans. <span><span class="ref-journal">Bioinformatics. </span>2010;<span class="ref-vol">26</span>:2190–2191.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2922887/">PMC free article</a>]</span> [<a href="/pubmed/20616382" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=METAL:+Fast+and+efficient+meta-analysis+of+genomewide+association+scans&amp;author=CJ+Willer&amp;author=Y+Li&amp;author=GR+Abecasis&amp;volume=26&amp;publication_year=2010&amp;pages=2190-2191&amp;pmid=20616382&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="element-citation">Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. <span><span class="ref-journal">Biometrics. </span>2000;<span class="ref-vol">56</span>:337–344.</span> [<a href="/pubmed/10877287" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biometrics&amp;title=Time-dependent+ROC+curves+for+censored+survival+data+and+a+diagnostic+marker&amp;author=PJ+Heagerty&amp;author=T+Lumley&amp;author=MS+Pepe&amp;volume=56&amp;publication_year=2000&amp;pages=337-344&amp;pmid=10877287&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="element-citation">Xia K, Shabalin AA, Huang S, et al.  SeeQTL: A searchable database for human eQTLs. <span><span class="ref-journal">Bioinformatics. </span>2012;<span class="ref-vol">28</span>:451–452.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3268245/">PMC free article</a>]</span> [<a href="/pubmed/22171328" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=SeeQTL:+A+searchable+database+for+human+eQTLs&amp;author=K+Xia&amp;author=AA+Shabalin&amp;author=S+Huang&amp;volume=28&amp;publication_year=2012&amp;pages=451-452&amp;pmid=22171328&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="element-citation">Gustafson HL, Yao S, Goldman BH, et al.  Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma. <span><span class="ref-journal">Am J Hematol. </span>2014;<span class="ref-vol">89</span>:639–645.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4137041/">PMC free article</a>]</span> [<a href="/pubmed/24633940" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hematol&amp;title=Genetic+polymorphisms+in+oxidative+stress-related+genes+are+associated+with+outcomes+following+treatment+for+aggressive+B-cell+non-Hodgkin+lymphoma&amp;author=HL+Gustafson&amp;author=S+Yao&amp;author=BH+Goldman&amp;volume=89&amp;publication_year=2014&amp;pages=639-645&amp;pmid=24633940&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="element-citation">Kim MK, Suh C, Chi HS, et al.  VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma. <span><span class="ref-journal">Cancer Science. </span>2012;<span class="ref-vol">103</span>:497–503.</span> [<a href="/pubmed/22129133" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Science&amp;title=VEGFA+and+VEGFR2+genetic+polymorphisms+and+survival+in+patients+with+diffuse+large+B+cell+lymphoma&amp;author=MK+Kim&amp;author=C+Suh&amp;author=HS+Chi&amp;volume=103&amp;publication_year=2012&amp;pages=497-503&amp;pmid=22129133&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="element-citation">Wong E, Bejarano E, Rakshit M, et al.  Molecular determinants of selective clearance of protein inclusions by autophagy. <span><span class="ref-journal">Nat Commun. </span>2012;<span class="ref-vol">3</span>:1240.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3526956/">PMC free article</a>]</span> [<a href="/pubmed/23212369" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=Molecular+determinants+of+selective+clearance+of+protein+inclusions+by+autophagy&amp;author=E+Wong&amp;author=E+Bejarano&amp;author=M+Rakshit&amp;volume=3&amp;publication_year=2012&amp;pages=1240&amp;pmid=23212369&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="element-citation">Worby CA, Dixon JE. Sorting out the cellular functions of sorting nexins. <span><span class="ref-journal">Nat Rev Mol Cell Biol. </span>2002;<span class="ref-vol">3</span>:919–931.</span> [<a href="/pubmed/12461558" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Mol+Cell+Biol&amp;title=Sorting+out+the+cellular+functions+of+sorting+nexins&amp;author=CA+Worby&amp;author=JE+Dixon&amp;volume=3&amp;publication_year=2002&amp;pages=919-931&amp;pmid=12461558&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="element-citation">Northcott PA, Shih DJ, Peacock J, et al.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes. <span><span class="ref-journal">Nature. </span>2012;<span class="ref-vol">488</span>:49–56.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3683624/">PMC free article</a>]</span> [<a href="/pubmed/22832581" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Subgroup-specific+structural+variation+across+1,000+medulloblastoma+genomes&amp;author=PA+Northcott&amp;author=DJ+Shih&amp;author=J+Peacock&amp;volume=488&amp;publication_year=2012&amp;pages=49-56&amp;pmid=22832581&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="element-citation">Xiao W, Shameli A, Harding C, et al.  B cell development is regulated by a-synuclein, a key player in Parkinson's disease. <span><span class="ref-journal">Blood. </span>2013;<span class="ref-vol">122</span>:785.</span> (abstr) <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=B+cell+development+is+regulated+by+a-synuclein,+a+key+player+in+Parkinson's+disease&amp;author=W+Xiao&amp;author=A+Shameli&amp;author=C+Harding&amp;volume=122&amp;publication_year=2013&amp;pages=785&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="element-citation">Ernst T, Score J, Deininger M, et al.  Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia. <span><span class="ref-journal">Br J Haematol. </span>2011;<span class="ref-vol">153</span>:43–46.</span> [<a href="/pubmed/21391972" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Haematol&amp;title=Identification+of+FOXP1+and+SNX2+as+novel+ABL1+fusion+partners+in+acute+lymphoblastic+leukaemia&amp;author=T+Ernst&amp;author=J+Score&amp;author=M+Deininger&amp;volume=153&amp;publication_year=2011&amp;pages=43-46&amp;pmid=21391972&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="element-citation">Ogi S, Fujita H, Kashihara M, et al.  Sorting nexin 2-mediated membrane trafficking of c-Met contributes to sensitivity of molecular-targeted drugs. <span><span class="ref-journal">Cancer Sci. </span>2013;<span class="ref-vol">104</span>:573–583.</span> [<a href="/pubmed/23360489" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Sci&amp;title=Sorting+nexin+2-mediated+membrane+trafficking+of+c-Met+contributes+to+sensitivity+of+molecular-targeted+drugs&amp;author=S+Ogi&amp;author=H+Fujita&amp;author=M+Kashihara&amp;volume=104&amp;publication_year=2013&amp;pages=573-583&amp;pmid=23360489&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="element-citation">Rombouts K, Carloni V, Mello T, et al.  Myristoylated alanine-rich protein kinase C substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo. <span><span class="ref-journal">Cancer Lett. </span>2013;<span class="ref-vol">333</span>:244–252.</span> [<a href="/pubmed/23376641" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Lett&amp;title=Myristoylated+alanine-rich+protein+kinase+C+substrate+(MARCKS)+expression+modulates+the+metastatic+phenotype+in+human+and+murine+colon+carcinoma+in+vitro+and+in+vivo&amp;author=K+Rombouts&amp;author=V+Carloni&amp;author=T+Mello&amp;volume=333&amp;publication_year=2013&amp;pages=244-252&amp;pmid=23376641&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="element-citation">Hartwig JH, Thelen M, Rosen A, et al.  MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. <span><span class="ref-journal">Nature. </span>1992;<span class="ref-vol">356</span>:618–622.</span> [<a href="/pubmed/1560845" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=MARCKS+is+an+actin+filament+crosslinking+protein+regulated+by+protein+kinase+C+and+calcium-calmodulin&amp;author=JH+Hartwig&amp;author=M+Thelen&amp;author=A+Rosen&amp;volume=356&amp;publication_year=1992&amp;pages=618-622&amp;pmid=1560845&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="element-citation">Blackshear PJ. The MARCKS family of cellular protein kinase C substrates. <span><span class="ref-journal">J Biol Chem. </span>1993;<span class="ref-vol">268</span>:1501–1504.</span> [<a href="/pubmed/8420923" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=The+MARCKS+family+of+cellular+protein+kinase+C+substrates&amp;author=PJ+Blackshear&amp;volume=268&amp;publication_year=1993&amp;pages=1501-1504&amp;pmid=8420923&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="element-citation">Jin Cho S, La M, Ahn JK, et al.  Tob-mediated cross-talk between MARCKS phosphorylation and ErbB-2 activation. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2001;<span class="ref-vol">283</span>:273–277.</span> [<a href="/pubmed/11327693" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Tob-mediated+cross-talk+between+MARCKS+phosphorylation+and+ErbB-2+activation&amp;author=S+Jin+Cho&amp;author=M+La&amp;author=JK+Ahn&amp;volume=283&amp;publication_year=2001&amp;pages=273-277&amp;pmid=11327693&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="element-citation">Min SK, Koh YH, Park Y, et al.  Expression of HAT1 and HDAC1, 2, 3 in diffuse large B-cell lymphomas, peripheral T-cell lymphomas, and NK/T-cell lymphomas. <span><span class="ref-journal">Korean J Pathol. </span>2012;<span class="ref-vol">46</span>:142–150.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3479788/">PMC free article</a>]</span> [<a href="/pubmed/23109994" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Korean+J+Pathol&amp;title=Expression+of+HAT1+and+HDAC1,+2,+3+in+diffuse+large+B-cell+lymphomas,+peripheral+T-cell+lymphomas,+and+NK/T-cell+lymphomas&amp;author=SK+Min&amp;author=YH+Koh&amp;author=Y+Park&amp;volume=46&amp;publication_year=2012&amp;pages=142-150&amp;pmid=23109994&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="element-citation">Marquard L, Poulsen CB, Gjerdrum LM, et al.  Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas. <span><span class="ref-journal">Histopathology. </span>2009;<span class="ref-vol">54</span>:688–698.</span> [<a href="/pubmed/19438744" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Histopathology&amp;title=Histone+deacetylase+1,+2,+6+and+acetylated+histone+H4+in+B-+and+T-cell+lymphomas&amp;author=L+Marquard&amp;author=CB+Poulsen&amp;author=LM+Gjerdrum&amp;volume=54&amp;publication_year=2009&amp;pages=688-698&amp;pmid=19438744&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="element-citation">Parikh K, Cang S, Sekhri A, et al.  Selective inhibitors of nuclear export (SINE): A novel class of anti-cancer agents. <span><span class="ref-journal">J Hematol Oncol. </span>2014;<span class="ref-vol">7</span>:78.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4200201/">PMC free article</a>]</span> [<a href="/pubmed/25316614" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hematol+Oncol&amp;title=Selective+inhibitors+of+nuclear+export+(SINE):+A+novel+class+of+anti-cancer+agents&amp;author=K+Parikh&amp;author=S+Cang&amp;author=A+Sekhri&amp;volume=7&amp;publication_year=2014&amp;pages=78&amp;pmid=25316614&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4879713&amp;issue-id=260998&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140044666014224title">Abstract</a></li><li><a href="#__sec5title">INTRODUCTION</a></li><li><a href="#__sec6title">METHODS</a></li><li><a href="#__sec10title">RESULTS</a></li><li><a href="#__sec17title">DISCUSSION</a></li><li><a href="#__sec18title">Supplementary Material</a></li><li><a href="#idm140044742909296title">Acknowledgment</a></li><li><a href="#idm140044742912608title">Footnotes</a></li><li><a href="#__sec19title">AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST</a></li><li><a href="#__sec20title">AUTHOR CONTRIBUTIONS</a></li><li><a href="#__sec21title">AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST</a></li><li><a href="#idm140044670775584title">REFERENCES</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Journal of Clinical Oncology</span> are provided here courtesy of <strong>American Society of Clinical Oncology</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC4879713/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC4879713/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC4879713/pdf/zlj3930.pdf">PDF (767K)</a></li> | <li><a href="#" data-citationid="PMC4879713" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4879713%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4879713%2F&amp;text=Genome-Wide%20Association%20Study%20of%20Event-Free%20Survival%20in%20Diffuse%20Large%20B-Cell%20Lymphoma%20Treated%20With%20Immunochemotherapy" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4879713%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="26460308" data-aiid="4879713" data-aid="4879713" data-iid="260998" data-domainid="660" data-domain="jco" data-accid="PMC4879713" data-md5="7b922a07a449cffe1166d9d7aca015d9"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T14:10:24-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal103&amp;ncbi_phid=CE8A2777DD5868D10000000005F2035A&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4879713%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=jco&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC4879713/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>